SCHEMBL9540160

SCHEMBL9540160

COc1ccc(CN2C(=O)NC(CC(C)(C)C)(C3CC3)c3cc(Cl)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.46
SCN9A Q15858 2/20 0.42
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
CMA1 P23946 1/20 0.40
BLM P54132 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CHRM5 P08912 2/20 0.38
OPRL1 P41146 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540078 0.89 PTGDR2 (0.49) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9540101 0.88 PTGDR2 (0.46) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9539009 0.88 PTGDR2 (0.46) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9542778 0.87 PTGDR2 (0.47) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9539778 0.86 PTGDR2 (0.45) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9540137 0.86 PTGDR2 (0.47) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9539775 0.85 PTGDR2 (0.44) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9540149 0.85 PTGDR2 (0.48) PTGDR2SCN9AMEN1ALDH1A1KMT2A
SCHEMBL9541586 0.85 PTGDR2 (0.45) PTGDR2SCN9AOPRL1
SCHEMBL9539952 0.85 PTGDR2 (0.43) PTGDR2SCN9AMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed